Researchers at Washington University School of Medicine in St. Louis have developed a potential antibody-based approach to ...
Treatment options for patients with relapsed/refractory follicular lymphoma have expanded rapidly. CD19-directed CAR T-cell therapies are approved in the third-line setting and beyond, and CD20 x CD3 ...
AstraZeneca will put about $2 billion into Summit after the latter flagged in July that its cash pile was not enough to fund planned operations for a full year.
There is no treatment available today to stop the death of brain cells in neurodegenerative diseases known as tauopathies, ...
Irish Mirror on MSN
GP explains reason some children get nasal flu spray rather than a jab
An NHS GP has explained how nasal and injected flu vaccines protect children, and how age and certain health conditions ...
Daiichi Sankyo and Merck announces ifinatamab deruxtecan BLA for certain patients with previously treated ES-SCLC voluntarily withdrawn: Rahway, New Jersey Monday, September 28, 2 ...
Xilio Therapeutics Inc. (Nasdaq: XLO) has appointed Yariv J. Houvras, M.D., Ph.D., as chief medical officer, adding an oncology drug... Read More ...
How this list was built Scope. Every biotech initial public offering with a first trading day between 1 January and 24 ...
Researchers analyzed 44 Bundibugyo virus genomes and modeled how approved and experimental Ebola antibodies might bind the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results